Chemical Compound

Bortezomib

CAS Registry Number 179324-69-7
Bortezomib chemical structure
Primary Record

Bortezomib

In stock
3,148 g
Purity
98.7 %
CAS
179324-69-7

Compound Identifiers & Properties

CAS
179324-69-7
PubChem CID
387447
SMILES
B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
Canonical SMILES
CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O

Names & Synonyms

  • Bortezomib
  • Velcade
  • 179324-69-7
  • radiciol
  • PS-341
  • Bortezomib (PS-341)
  • bortezomibum
  • Bortexomib
  • Zindoxifene
  • Bortezomib accord
  • Pyz-Phe-boroLeu
  • Peptide boronate
  • Velcade (TN)
  • Bortezomib hydrate
  • LDP-341
  • Bortezomib,Velcade
  • DPBA
  • Bortezomib (Velcade)
  • Bortezomib [USAN]
  • Velcade (Millenium)
  • BORUZU
  • Ps 341
  • Bortezomib (Standard)
  • RefChem:5614
  • 3mg0
  • BORTEZOMIB [MI]
  • Bortezomib for Injection
  • PS 341 (pharmaceutical)
  • C19H25BN4O4
  • AC1L8TUW
  • BORTEZOMIB [INN]
  • BORTEZOMIB [JAN]
  • Bortezomib [USAN:INN]
  • LDP 341
  • MLN-341
  • 69G8BD63PP
  • BORTEZOMIB [HSDB]
  • PS-341 [Bortezomib]
  • PS-341[pharmaceutical]
  • UNII-69G8BD63PP
  • Boronic acid, L-(S)-
  • NSC-681239
  • PROSCRIPT BORONIC ACID
  • BORTEZOMIB [VANDF]
  • DTXSID3040980
  • MFCD09056737
  • cc-75
  • D0SH3I
  • Bortezomib [USAN:INN:BAN]
  • BORTEZOMIB [MART.]
  • LPD-341
  • CHEMBL325041
  • LDP341
  • BORTEZOMIB [WHO-DD]
  • Bortezomib(JAN/USAN/INN)
  • MG-341
  • DTXCID1020980
  • CHEBI:52717
  • HSDB 7666
  • MLS004774142
  • Bortezomib (JAN/USAN/INN)
  • BORTEZOMIB [EMA EPAR]
  • SCHEMBL192129
  • LPD 341
  • GXJABQQUPOEUTA-RDJZCZTQSA-N
  • Bortezomib - Bio-X trade mark
  • GTPL6391
  • orb1305542
  • PS341
  • Peptidyl boronic acid derivative
  • Bortezomib (Mixture of isomers)
  • BORTEZOMIB [ORANGE BOOK]
  • BORTEZOMIB HYDRATE [JAN]
  • SCHEMBL29377226
  • CTK8B8979
  • AOB6368
  • Bortezomib (Proteasome inhibitor)
  • L01XX32
  • Dipeptidyl boronic acid derivative
  • MG 341
  • NSC681239
  • GLXC-05159
  • NSC 681239
  • 341, PS
  • EX-A8373
  • Bortezomib, 98% - 25MG 25mg
  • Tox21_112630
  • Tox21_112672
  • ((R)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid
  • ABP000234
  • ANW-61718
  • BBF-05860
  • BDBM50069989
  • C19-H25-B-N4-O4
  • CB0261
  • CID387447
  • EBC-11290
  • HB4036
  • HY-10227R
  • MFCD27978443
  • NCGC00242506-02
  • NSC756655
  • AKOS015909706
  • Tox21_112672_1
  • ZINC169746649
  • [(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
  • ACN-030054
  • AM81235
  • CCG-268449
  • CID:387447
  • CS-1039
  • CS-O-00482
  • DB00188
  • FM19000
  • MG-341; PS-341
  • NSC-756655
  • RL02288
  • Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-
  • Bortezomib/Velcade, MG-341, PS-341
  • NCGC00168751-01
  • NCGC00181022-01
  • NCGC00242506-01
  • NCGC00242506-06
  • NCGC00242506-07
  • S1013
  • AS-15721
  • BB164258
  • BC201423
  • HY-10227
  • NCI60_029010
  • Q425
  • SC-23571
  • SMR003500787
  • SY008095
  • Bortezomib (Velcade,MG-341,PS-341)?
  • SID:283537489
  • Velcade, MG-341, PS-341, Bortezomib
  • AB0017579
  • AB2000734
  • RT-000308
  • ST2406732
  • A2614
  • B5741
  • CAS-179324-69-7
  • N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE
  • NS00006197
  • SW208077-3
  • J1.921.292K
  • KS-00000761
  • [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid
  • A10160
  • A18332
  • D03150
  • EN300-657180
  • Q-4365
  • AB01273951-01
  • AB01273951-02
  • AB01273951_03
  • 324B697
  • C400082
  • Q419319
  • SR-01000939863
  • I14-3268
  • SR-01000939863-2
  • BRD-K88510285-001-02-0
  • BRD-K88510285-001-11-1
  • BRD-K88510285-001-17-8
  • BRD-K88510285-001-18-6
  • Velcade, MG-341, PS-341,179324-69-7
  • D000069286
  • Z2213886907
  • [(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid
  • [(1R)-3-METHYL-1-[[(2S)-1-OXO-3-PHENYL-2-[(PYRAZINYLCARBONYL)AMINO]PROPYL]AMINO]BUTYL]-BORONIC ACID
  • Boronic acid, ((1R)-3-methyl-1-(((2S)-1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-
  • N-((1S)-1-Benzyl-2-(((1R)-1-(dihydroxyboranyl)-3-methylbutyl)amino)-2-oxoethyl)pyrazinecarboxamide
  • n-(2-pyrazine)carbonyl-l-phenylalanine-l-leucine boronic acid
  • (R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butylboronic acid
  • [(1R)-3-methyl-1-[(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanamido]butyl]boronic acid
  • N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide
  • ((1R)-3-Methyl-1-(((2S)-3-phenyl-2-((pyrazinylcarbonyl)amino)propanoyl)amino)butyl)boronic acid
  • BO2
  • ((1R)-3-methyl-1-((2S)-3-phenyl-2-(pyrazin-2-ylformamido)propanamido)butyl)boronic acid
  • ((R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronicacid
  • (R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-6-carboxamido)propanamido)butylboronic acid
  • N-((1R)-1-(DIHYDROXYBORYL)-3-methylbutyl)-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide
  • N-[(1R)-1-Borono-3-methylbutyl]-Nalpha-(pyrazine-2-carbonyl)-L-phenylalaninamide
  • ((1R)-3-methyl-1-(((2S)-3-phenyl-2-((pyrazin-2-ylcarbonyl)amino)propanoyl)amino)butyl)boronic acid
  • (1R)-3-Methyl-1-({(2S)-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propanoyl}amino)butylboronic acid, AldrichCPR
  • (2S)-N-((1R)-1-Dihydroxyboryl-3-methylbutane-1-yl)-2-(2-pyrazinylcarbonylamino)-3-phenylpropanamide
  • (R)-3-METHYL-1-((S)-3-PHENYL-2-(PYRAZINE-2-CARBOXAMIDO)PROPANAMIDO)BUTAN-2-YLBORONIC ACID
  • [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid
  • [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]-butyl]boronic acid
  • [(1R)-3-Methyl-1-[[(2S)-3-phenyl-2-[(pyrazinylcarbonyl)amino]propanoyl]amino]butyl]boronic acid
  • 1610526-91-4
  • Boronic acid, (3-methyl-1-((1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-, (S-(R*,S*))-
  • Boronic acid, [(1(R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-
  • Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-; Boronic acid, [(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]- (9CI); Boronic acid, [3-methyl-1-[[1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-, [S-(R*,S*)]-; Bortezomib; DPBA; LDP 341; MG 341; MLN 341; NSC 681239; PS 314; PS 341; PS 341 (pharmaceutical); Radiciol; Velcade
  • Boronic acid,B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-
  • BTZ
  • N-((1S)-1-benzyl-2-(((1R)-1-(dihydroxyboranyl)-3-methylbutyl)amino)2-oxoethylpyrazinecarboxamide
  • N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-N(alpha)-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide